Hematology NewsTriple therapy ups response in refractory mantle cell lymphomaFebruary 4, 2018Mantle Cell LymphomaIndolent LymphomaLymphoma & Plasma Cell Disorders
Oncology PracticeBackground color a dermoscopic clue to cutaneous B-cell lymphomaJanuary 30, 2018Lymphoma & Plasma Cell DisordersIndolent LymphomaB Cell Lymphoma
Hematology NewsAUDIO: Immunotherapy’s role in NHLJanuary 11, 2018Aggressive LymphomasIndolent Lymphoma
Hematology NewsBTK inhibitor zanubrutinib active in non-Hodgkin lymphomasJanuary 2, 2018Mantle Cell LymphomaIndolent LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Oncology PracticePemphigus associated with higher risk of hematologic malignanciesDecember 28, 2017Lymphoma & Plasma Cell DisordersIndolent Lymphoma
Hematology NewsStudy identifies predictors of acquired von Willebrand diseaseDecember 26, 2017Indolent LymphomaLymphoma & Plasma Cell DisordersBleeding Disorders
Hematology NewsRare neurological complication linked to Waldenstrom diseaseDecember 18, 2017Indolent LymphomaAnemia
Hematology NewsUpdated ZUMA-1 data show durable CAR-T responses in B-cell lymphomasDecember 10, 2017Aggressive LymphomasCellular TherapyIndolent LymphomaLymphoma & Plasma Cell DisordersImmunotherapyImmuno-oncologyFollicular Lymphoma
Hematology NewsRare epidermotropic MZL yields to rituximabNovember 27, 2017Indolent LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsUpfront chemotherapy yields excellent survival in patients with MZLsNovember 27, 2017Indolent LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsMarginal zone lymphoma treatment studies to be presented at ASHNovember 27, 2017Indolent LymphomaFollicular Lymphoma
